Sponsored
Experts talk about the impact of a collaborative and supportive patient-provider relationship in the management of IBS-C and CIC.
Amy Ladewski, PA-C
Advertisement
Articles by Amy Ladewski, PA-C
Sponsored
Thought leaders explore premature treatment discontinuation and some of the reasons leading to it, such as time to response and safety in regards to the use of prescription therapies for IBS-C and CIC.
Sponsored
Experts discuss the current use of OTC and review guidelines for prescription treatments for IBS-C and CIC.
Sponsored
Thought leaders review prevalence, common symptoms, and patient burden of IBS-C and CIC.
Advertisement
Latest Updated Articles
The Importance of the Patient-Provider RelationshipDecember 17th 2024
- IBS-C and CIC Overview
December 17th 2024
- Premature Treatment Discontinuation (Time to Response)
December 17th 2024
- Over-the-Counter and Prescription Treatment Guidelines and Use
December 17th 2024
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Clears Wave Neuroscience MeRT System for PTSD
2
AD109 Reduces OSA Severity in Phase 3 Trial of CPAP-Intolerant Adults
3
ACS Colorectal Cancer Screening Update: Implications for Primary Care
4
7 Late-Breaking Clinical Trials to Watch For at SLEEP 2026
5